FFP
PFE icon

FourThought Financial Partners’s Pfizer PFE Stock Holding History

FourThought Financial Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$403K Sell
16,740
-569
-3% -$14.9K 0.03% 228
2026
Q1 		$486K Sell
17,309
-2,468
-12% -$65.7K 0.04% 188
2025
Q4 		$492K Sell
19,777
-1,688
-8% -$42.6K 0.04% 213
2025
Q3 		$547K Sell
21,465
-6,431
-23% -$159K 0.05% 183
2025
Q2 		$676K Sell
27,896
-3,618
-11% -$84.4K 0.07% 161
2025
Q1 		$799K Sell
31,514
-178
-0.6% -$4.66K 0.08% 147
2024
Q4 		$841K Buy
+31,692
New +$860K 0.09% 146
2024
Q2 		– Sell
-32,238
Closed -$895K – 287
2024
Q1 		$895K Sell
32,238
-686
-2% -$19K 0.1% 143
2023
Q4 		$948K Buy
32,924
+146
+0.4% +$4.41K 0.12% 132
2023
Q3 		$1.09M Buy
32,778
+2,739
+9% +$96.9K 0.15% 106
2023
Q2 		$1.1M Sell
30,039
-1,749
-6% -$68.1K 0.14% 112
2023
Q1 		$1.3M Buy
31,788
+1,257
+4% +$54.3K 0.18% 106
2022
Q4 		$1.56M Buy
+30,531
New +$1.46M 0.23% 94

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

FourThought Financial Partners's PFE Position: Q2 2026 in Review

FourThought Financial Partners reduced its Pfizer (PFE) stake by 3.3% in Q2 2026, selling an estimated $14.9K and leaving 16,740 shares worth $403K. The position accounts for 0.03% of the portfolio, ranked #228.

FourThought Financial Partners first reported a position in PFE in Q4 2022 and has held it in 13 quarters since. The position peaked at $1.56M in Q4 2022. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • FourThought Financial Partners held 16,740 shares of Pfizer worth $403K as of Q2 2026.
  • FourThought Financial Partners sold 569 Pfizer shares in Q2 2026, an estimated $14.9K.
  • Pfizer made up 0.03% of FourThought Financial Partners's portfolio in Q2 2026, its #228 holding.
  • FourThought Financial Partners first reported a position in Pfizer in Q4 2022 and has held it in 13 quarters since.
  • FourThought Financial Partners's Pfizer position peaked at $1.56M in Q4 2022.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on FourThought Financial Partners's 13F filing for Q2 2026, filed 12 Aug 2026.